STROME MARK E 13D/13G Filings for Cue Biopharma, Inc. (CUE)

STROME MARK E 13D and 13G filings for Cue Biopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-16
4:01 pm
Purchase
2022-11-1413GCue Biopharma, Inc.
CUE
STROME MARK E2,166,242
4.990%
1,375,630increase
(+174.00%)
Filing